Michael E. Rothenberg

Biohaven Pharmaceuticals (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Rates of Major Cardiovascular Events in Severe Asthma: U.S. Real-World and Clinical Trial–Eligible Populations”.

Rates of Major Cardiovascular Events in Severe Asthma: U.S. Real-World and Clinical Trial–Eligible Populations

Annals of the American Thoracic Society(2021)10.1513/annalsats.202010-1349rl

N/A

0DataRank · unranked

2 citations

Carlos Iribarren, Dorothy Cheung, Michael E. Rothenberg, C. Victor Spain, Parul Dayal

Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells

Journal of Gastroenterology(2022)10.1007/s00535-022-01865-9

N/A

0DataRank · unranked

8 citations

Junko Mukohyama, Sanjay Koul, Takanori Hayashi, Michael E. Rothenberg, Masao Maeda +13 more

Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects

Science Translational Medicine(2023)10.1126/scitranslmed.adf8366

N/A

0DataRank · unranked

18 citations

Seihwan Jeong, Alberto Utrero‐Rico, Tatiana Goncharov, Joshua D. Webster, Ernst Holler +7 more